OCGN Market Cap History



Below is a table of the OCGN market cap history going back to 9/30/2019:

Date OCGN Market Cap
9/30/20194.49M
11/7/201918.56M
3/20/202016.10M
4/27/202023.86M
5/1/202025.05M
8/7/202074.25M
10/30/202045.53M
3/1/20211.88B
4/30/20212.51B
7/30/20211.33B
11/2/20213.12B
2/21/2022690.23M
4/29/2022472.30M
7/29/2022558.74M
11/1/2022372.11M
2/21/2023218.72M
4/28/2023161.67M
8/14/2023126.19M
11/2/202395.16M

Also see: OCGN Shares Outstanding History
and OCGN YTD Return
OCGN Historical Market Cap:
+110.83% CAGR
OCGN Historical Market Cap: +110.83% CAGR

Mouse over chart for data details
9/30/2019 ...11/2/2023
Ocugen is a clinical-stage biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Co. develops, manufactures, and commercializes COVAXIN for the prevention of COVID-19. Co.'s gene therapy candidate, OCU400 is for the treatment of certain disease genotypes: nuclear receptor subfamily 2 group E member 3, centrosomal protein 290, rhodopsin, and phosphodiesterase 6B mutation-associated inherited retinal degenerations. Co.'s second gene therapy candidate, OCU410, is being developed to utilize the nuclear receptor genes RAR-related orphan receptor A for the treatment of dry age-related macular degeneration. We show 19 historical shares outstanding datapoints in our OCGN shares outstanding history coverage, used to compute OCGN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing OCGN market cap history over the course of time is important for investors interested in comparing OCGN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of OCGN versus a peer is one thing; comparing OCGN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like OCGN can fluctuate over the course of history. With this page we aim to empower investors researching OCGN by allowing them to research the OCGN market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree OCGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Ocugen (OCGN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

OCUL Market Cap History
OCUP Market Cap History
OCX Market Cap History
ODT Market Cap History
OFIX Market Cap History
OGN Market Cap History
OHRP Market Cap History
OLMA Market Cap History
OM Market Cap History
OMED Market Cap History
More Healthcare companies »

 

OCGN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.